rs72958116

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2

The ENST00000589116.2(CCBE1):​n.943C>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.012 in 1,603,590 control chromosomes in the GnomAD database, including 161 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.0095 ( 14 hom., cov: 32)
Exomes 𝑓: 0.012 ( 147 hom. )

Consequence

CCBE1
ENST00000589116.2 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.314

Publications

2 publications found
Variant links:
Genes affected
CCBE1 (HGNC:29426): (collagen and calcium binding EGF domains 1) This gene is thought to function in extracellular matrix remodeling and migration. It is predominantly expressed in the ovary, but down regulated in ovarian cancer cell lines and primary carcinomas, suggesting its role as a tumour suppressor. Mutations in this gene have been associated with Hennekam lymphangiectasia-lymphedema syndrome, a generalized lymphatic dysplasia in humans. [provided by RefSeq, Mar 2010]
CCBE1 Gene-Disease associations (from GenCC):
  • Hennekam lymphangiectasia-lymphedema syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • Hennekam syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00945 (1439/152214) while in subpopulation SAS AF = 0.0177 (85/4802). AF 95% confidence interval is 0.0147. There are 14 homozygotes in GnomAd4. There are 675 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 14 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CCBE1NM_133459.4 linkc.*14C>T 3_prime_UTR_variant Exon 11 of 11 ENST00000439986.9 NP_597716.1 Q6UXH8-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CCBE1ENST00000439986.9 linkc.*14C>T 3_prime_UTR_variant Exon 11 of 11 1 NM_133459.4 ENSP00000404464.2 Q6UXH8-1

Frequencies

GnomAD3 genomes
AF:
0.00944
AC:
1436
AN:
152096
Hom.:
13
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00266
Gnomad AMI
AF:
0.0275
Gnomad AMR
AF:
0.0156
Gnomad ASJ
AF:
0.00951
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0171
Gnomad FIN
AF:
0.00179
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0132
Gnomad OTH
AF:
0.0120
GnomAD2 exomes
AF:
0.0101
AC:
2533
AN:
250470
AF XY:
0.0110
show subpopulations
Gnomad AFR exome
AF:
0.00141
Gnomad AMR exome
AF:
0.00778
Gnomad ASJ exome
AF:
0.0135
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00245
Gnomad NFE exome
AF:
0.0125
Gnomad OTH exome
AF:
0.00929
GnomAD4 exome
AF:
0.0123
AC:
17829
AN:
1451376
Hom.:
147
Cov.:
27
AF XY:
0.0125
AC XY:
9025
AN XY:
722838
show subpopulations
African (AFR)
AF:
0.00192
AC:
64
AN:
33280
American (AMR)
AF:
0.00818
AC:
366
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0130
AC:
338
AN:
26078
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39644
South Asian (SAS)
AF:
0.0188
AC:
1619
AN:
86028
European-Finnish (FIN)
AF:
0.00210
AC:
112
AN:
53416
Middle Eastern (MID)
AF:
0.0145
AC:
83
AN:
5740
European-Non Finnish (NFE)
AF:
0.0131
AC:
14486
AN:
1102424
Other (OTH)
AF:
0.0127
AC:
760
AN:
60044
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
856
1712
2569
3425
4281
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
550
1100
1650
2200
2750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00945
AC:
1439
AN:
152214
Hom.:
14
Cov.:
32
AF XY:
0.00907
AC XY:
675
AN XY:
74434
show subpopulations
African (AFR)
AF:
0.00265
AC:
110
AN:
41542
American (AMR)
AF:
0.0156
AC:
238
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00951
AC:
33
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5174
South Asian (SAS)
AF:
0.0177
AC:
85
AN:
4802
European-Finnish (FIN)
AF:
0.00179
AC:
19
AN:
10598
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.0132
AC:
899
AN:
68014
Other (OTH)
AF:
0.0123
AC:
26
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
74
147
221
294
368
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0108
Hom.:
5
Bravo
AF:
0.00935
Asia WGS
AF:
0.00722
AC:
26
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Hennekam lymphangiectasia-lymphedema syndrome 1 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
4.1
DANN
Benign
0.52
PhyloP100
0.31
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72958116; hg19: chr18-57103126; COSMIC: COSV67949203; API